Maximize Returns on Dr. Reddy's Laboratories Ltd (RDY) Investments Using Our Online Dividend Calculator.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
LATAM AIRLINES GROUP SA SPON ADS EACH REP 2000 SHS
Encompass Health Corporation
Royal Gold Inc.
Western Midstream Partners LP Common Units Representing Limited Partner Interests
Banco Santander - Chile ADS
Vipshop Holdings Limited
Donaldson Company Inc.
Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)